Monday, October 26, 2020 7:53:32 AM
https://www.businesswire.com/news/home/20201026005289/en/Spectrum-Pharmaceuticals-Announces-that-the-FDA-is-Deferring-its-Action-on-the-BLA-for-ROLONTIS%C2%AE-eflapegrastim/?feedref=Zd8jjkgYuzBwDixoAdXmJgT1albrG1Eq4mAeVP39211KZpNY4nusb_QpY_g-4zdhevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxYoY3Ch5VGwf9D0wb9dzp5TtT_UavXl_CPeRGzmCyU-Rw==
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM